Skip to content

Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00761488
Enrollment
0
Registered
2008-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2015-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Visual acuity,, corneal and, refractive, cylinder, following, implantation of the, AcrySof® Toric

Brief summary

To allow surgeons to obtain clinical experience on the postoperative uncorrected and best distance corrected visual acuities (UCVA and BDCVA) and corneal and refractive cylinder of the AcrySof Toric IOL.

Interventions

Implanted into the study eye

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 40-80 years old; of any race and gender; diagnosed with bilateral cataracts; require cataract extraction followed by implantation of a posterior chamber IOL; patients have between 0.75 -2.5 D of astigmatism preoperatively as measured by K readings.

Exclusion criteria

* Females of child bearing potential;irregular corneal astigmatism;keratopathy/Keratectasia; cornea inflammation or edema;previous corneal reshaping,dystrophy or transplant;amblyopia;glaucoma;RPE/Macular changes;diabetic retinopathy.

Design outcomes

Primary

MeasureTime frame
Corneal astigmatism; IOL rotationBefore opertation; 1 day following implantation of each eye; 1, 3 months following lens implantation in the second eye.

Secondary

MeasureTime frame
Uncorrected and best distance corrected visual acuities (UCVA and BDCVA)Before opertation; 1 day following implantation of each eye; 1, 3 months following lens implantation in the second eye.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026